Skip to main content
Top
Published in: BMC Gastroenterology 1/2023

Open Access 01-12-2023 | Oral Microbiota | Research

Transmission of oral microbiota to the biliary tract during endoscopic retrograde cholangiography

Authors: Maria Effenberger, Ramona Al-Zoairy, Ronald Gstir, Ivo Graziadei, Hubert Schwaighofer, Herbert Tilg, Heinz Zoller

Published in: BMC Gastroenterology | Issue 1/2023

Login to get access

Abstract

Background

Endoscopic retrograde cholangiography (ERC) possesses a translocation risk of microbes to the biliary system. We studied bile contamination during ERC and its impact on patients’ outcome in a real-life-situation.

Methods

Ninety-nine ERCs were analyzed and microbial samples were taken from the throat before and from bile during ERC and from irrigation fluid of the duodenoscope before and after ERC.

Results

91.2% of cholangitis patients had detectable microbes in the bile (sensitivity 91%), but the same was true for 86.2% in the non-cholangitis group. Bacteroides fragilis (p=0.015) was significantly associated with cholangitis. In 41.7% of ERCs with contaminated endoscopes these microbes were found in the bile after the procedure. Analysis of duodenoscopes’ irrigation liquid after ERC matched the microbial bile analysis of these patients in 78.8%. Identical microbial species were in throat and in bile samples of the same ERC in 33% of all cases and in 45% in the non-cholangitis group. Transmission of microbes to the biliary tract did not result in more frequent cholangitis, longer hospital stays, or worse outcome.

Conclusions

During ERC bile samples are regularly contaminated with microbes of the oral cavity but it did not affect clinical outcome.
Appendix
Available only for authorised users
Literature
1.
go back to reference Nakai Y, Isayama H, Wang HP, Rerknimitr R, Khor C, Yasuda I, Kogure H, Moon JH, Lau J, Lakhtakia S, et al. International consensus statements for endoscopic management of distal biliary stricture. J Gastroenterol Hepatol. 2020;35(6):967–79.CrossRefPubMedPubMedCentral Nakai Y, Isayama H, Wang HP, Rerknimitr R, Khor C, Yasuda I, Kogure H, Moon JH, Lau J, Lakhtakia S, et al. International consensus statements for endoscopic management of distal biliary stricture. J Gastroenterol Hepatol. 2020;35(6):967–79.CrossRefPubMedPubMedCentral
2.
go back to reference Zhu Y, Tu J, Zhao Y, Jing J, Dong Z, Pan W. Association of timing of biliary drainage with clinical outcomes in severe acute cholangitis: a retrospective cohort study. Int J Gen Med. 2021;14:2953–63.CrossRefPubMedPubMedCentral Zhu Y, Tu J, Zhao Y, Jing J, Dong Z, Pan W. Association of timing of biliary drainage with clinical outcomes in severe acute cholangitis: a retrospective cohort study. Int J Gen Med. 2021;14:2953–63.CrossRefPubMedPubMedCentral
3.
go back to reference Manes G, Paspatis G, Aabakken L, Anderloni A, Arvanitakis M, Ah-Soune P, Barthet M, Domagk D, Dumonceau JM, Gigot JF, et al. Endoscopic management of common bile duct stones: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2019;51(5):472–91.CrossRefPubMed Manes G, Paspatis G, Aabakken L, Anderloni A, Arvanitakis M, Ah-Soune P, Barthet M, Domagk D, Dumonceau JM, Gigot JF, et al. Endoscopic management of common bile duct stones: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2019;51(5):472–91.CrossRefPubMed
4.
go back to reference Tan M. Schaffalitzky de Muckadell OB, Laursen SB: Association between early ERCP and mortality in patients with acute cholangitis. Gastrointest Endosc. 2018;87(1):185–92.CrossRefPubMed Tan M. Schaffalitzky de Muckadell OB, Laursen SB: Association between early ERCP and mortality in patients with acute cholangitis. Gastrointest Endosc. 2018;87(1):185–92.CrossRefPubMed
5.
go back to reference Visrodia KH, Ofstead CL, Yellin HL, Wetzler HP, Tosh PK, Baron TH. The use of rapid indicators for the detection of organic residues on clinically used gastrointestinal endoscopes with and without visually apparent debris. Infect Control Hosp Epidemiol. 2014;35(8):987–94.CrossRefPubMed Visrodia KH, Ofstead CL, Yellin HL, Wetzler HP, Tosh PK, Baron TH. The use of rapid indicators for the detection of organic residues on clinically used gastrointestinal endoscopes with and without visually apparent debris. Infect Control Hosp Epidemiol. 2014;35(8):987–94.CrossRefPubMed
6.
go back to reference Ribeiro MM, de Oliveira AC, Ribeiro SM, Watanabe E, de Resende Stoianoff MA, Ferreira JA. Effectiveness of flexible gastrointestinal endoscope reprocessing. Infect Control Hosp Epidemiol. 2013;34(3):309–12.CrossRefPubMed Ribeiro MM, de Oliveira AC, Ribeiro SM, Watanabe E, de Resende Stoianoff MA, Ferreira JA. Effectiveness of flexible gastrointestinal endoscope reprocessing. Infect Control Hosp Epidemiol. 2013;34(3):309–12.CrossRefPubMed
7.
go back to reference Brandabur JJ, Leggett JE, Wang L, Bartles RL, Baxter L, Diaz GA, Grunkemeier GL, Hove S, Oethinger M. Surveillance of guideline practices for duodenoscope and linear echoendoscope reprocessing in a large healthcare system. Gastrointest Endosc. 2016;84(3):392-399.e393.CrossRefPubMed Brandabur JJ, Leggett JE, Wang L, Bartles RL, Baxter L, Diaz GA, Grunkemeier GL, Hove S, Oethinger M. Surveillance of guideline practices for duodenoscope and linear echoendoscope reprocessing in a large healthcare system. Gastrointest Endosc. 2016;84(3):392-399.e393.CrossRefPubMed
8.
go back to reference Rubin ZA, Kim S, Thaker AM, Muthusamy VR. Safely reprocessing duodenoscopes: current evidence and future directions. Lancet Gastroenterol Hepatol. 2018;3(7):499–508.CrossRefPubMed Rubin ZA, Kim S, Thaker AM, Muthusamy VR. Safely reprocessing duodenoscopes: current evidence and future directions. Lancet Gastroenterol Hepatol. 2018;3(7):499–508.CrossRefPubMed
9.
go back to reference Andriulli A, Loperfido S, Napolitano G, Niro G, Valvano MR, Spirito F, Pilotto A, Forlano R. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol. 2007;102(8):1781–8.CrossRefPubMed Andriulli A, Loperfido S, Napolitano G, Niro G, Valvano MR, Spirito F, Pilotto A, Forlano R. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol. 2007;102(8):1781–8.CrossRefPubMed
10.
go back to reference Bilbao MK, Dotter CT, Lee TG, Katon RM. Complications of endoscopic retrograde cholangiopancreatography (ERCP). A study of 10,000 cases. Gastroenterology. 1976;70(3):314–20.CrossRefPubMed Bilbao MK, Dotter CT, Lee TG, Katon RM. Complications of endoscopic retrograde cholangiopancreatography (ERCP). A study of 10,000 cases. Gastroenterology. 1976;70(3):314–20.CrossRefPubMed
11.
go back to reference Kiriyama S, Kozaka K, Takada T, Strasberg SM, Pitt HA, Gabata T, Hata J, Liau KH, Miura F, Horiguchi A, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos). J Hepatobiliary Pancreat Sci. 2018;25(1):17–30.CrossRefPubMed Kiriyama S, Kozaka K, Takada T, Strasberg SM, Pitt HA, Gabata T, Hata J, Liau KH, Miura F, Horiguchi A, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos). J Hepatobiliary Pancreat Sci. 2018;25(1):17–30.CrossRefPubMed
12.
go back to reference Laboratory NCfC, Standards: Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A6. Villanova: NCCLS; 2002. Laboratory NCfC, Standards: Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A6. Villanova: NCCLS; 2002.
13.
go back to reference Gromski MA, Gutta A, Lehman GA, Tong Y, Fogel EL, Watkins JL, Easler JJ, Bick B, McHenry L, Beeler C, et al. Microbiology of bile aspirates obtained at ERCP in patients with suspected acute cholangitis. Endoscopy. 2022;54(11):1045–52.CrossRefPubMedPubMedCentral Gromski MA, Gutta A, Lehman GA, Tong Y, Fogel EL, Watkins JL, Easler JJ, Bick B, McHenry L, Beeler C, et al. Microbiology of bile aspirates obtained at ERCP in patients with suspected acute cholangitis. Endoscopy. 2022;54(11):1045–52.CrossRefPubMedPubMedCentral
14.
go back to reference Kullman E, Borch K, Lindstrom E, Ansehn S, Ihse I, Anderberg B. Bacteremia following diagnostic and therapeutic ERCP. Gastrointest Endosc. 1992;38(4):444–9.CrossRefPubMed Kullman E, Borch K, Lindstrom E, Ansehn S, Ihse I, Anderberg B. Bacteremia following diagnostic and therapeutic ERCP. Gastrointest Endosc. 1992;38(4):444–9.CrossRefPubMed
15.
go back to reference Negm AA, Schott A, Vonberg RP, Weismueller TJ, Schneider AS, Kubicka S, Strassburg CP, Manns MP, Suerbaum S, Wedemeyer J, et al. Routine bile collection for microbiological analysis during cholangiography and its impact on the management of cholangitis. Gastrointest Endosc. 2010;72(2):284–91.CrossRefPubMed Negm AA, Schott A, Vonberg RP, Weismueller TJ, Schneider AS, Kubicka S, Strassburg CP, Manns MP, Suerbaum S, Wedemeyer J, et al. Routine bile collection for microbiological analysis during cholangiography and its impact on the management of cholangitis. Gastrointest Endosc. 2010;72(2):284–91.CrossRefPubMed
16.
go back to reference Rupp C, Bode K, Weiss KH, Rudolph G, Bergemann J, Kloeters-Plachky P, Chahoud F, Stremmel W, Gotthardt DN, Sauer P. Microbiological assessment of bile and corresponding antibiotic treatment: a strobe-compliant observational study of 1401 endoscopic retrograde cholangiographies. Medicine (Baltimore). 2016;95(10): e2390.CrossRefPubMed Rupp C, Bode K, Weiss KH, Rudolph G, Bergemann J, Kloeters-Plachky P, Chahoud F, Stremmel W, Gotthardt DN, Sauer P. Microbiological assessment of bile and corresponding antibiotic treatment: a strobe-compliant observational study of 1401 endoscopic retrograde cholangiographies. Medicine (Baltimore). 2016;95(10): e2390.CrossRefPubMed
17.
go back to reference Qin N, Yang F, Li A, Prifti E, Chen Y, Shao L, Guo J, Le Chatelier E, Yao J, Wu L, et al. Alterations of the human gut microbiome in liver cirrhosis. Nature. 2014;513(7516):59–64.CrossRefPubMed Qin N, Yang F, Li A, Prifti E, Chen Y, Shao L, Guo J, Le Chatelier E, Yao J, Wu L, et al. Alterations of the human gut microbiome in liver cirrhosis. Nature. 2014;513(7516):59–64.CrossRefPubMed
18.
go back to reference Dubinkina VB, Tyakht AV, Odintsova VY, Yarygin KS, Kovarsky BA, Pavlenko AV, Ischenko DS, Popenko AS, Alexeev DG, Taraskina AY, et al. Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease. Microbiome. 2017;5(1):141.CrossRefPubMedPubMedCentral Dubinkina VB, Tyakht AV, Odintsova VY, Yarygin KS, Kovarsky BA, Pavlenko AV, Ischenko DS, Popenko AS, Alexeev DG, Taraskina AY, et al. Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease. Microbiome. 2017;5(1):141.CrossRefPubMedPubMedCentral
19.
go back to reference Wu T, Zhang Z, Liu B, Hou D, Liang Y, Zhang J, Shi P. Gut microbiota dysbiosis and bacterial community assembly associated with cholesterol gallstones in large-scale study. BMC Genomics. 2013;14:669.CrossRefPubMedPubMedCentral Wu T, Zhang Z, Liu B, Hou D, Liang Y, Zhang J, Shi P. Gut microbiota dysbiosis and bacterial community assembly associated with cholesterol gallstones in large-scale study. BMC Genomics. 2013;14:669.CrossRefPubMedPubMedCentral
20.
go back to reference Lenz P, Conrad B, Kucharzik T, Hilker E, Fegeler W, Ullerich H, Heinecke A, Domschke W, Domagk D. Prevalence, associations, and trends of biliary-tract candidiasis: a prospective observational study. Gastrointest Endosc. 2009;70(3):480–7.CrossRefPubMed Lenz P, Conrad B, Kucharzik T, Hilker E, Fegeler W, Ullerich H, Heinecke A, Domschke W, Domagk D. Prevalence, associations, and trends of biliary-tract candidiasis: a prospective observational study. Gastrointest Endosc. 2009;70(3):480–7.CrossRefPubMed
21.
go back to reference Forbes N, Elmunzer BJ, Allain T, Chau M, Koury HF, Bass S, Belletrutti PJ, Cole MJ, Gonzalez-Moreno E, Kayal A, et al. Infection control in ERCP using a duodenoscope with a disposable cap (ICECAP): rationale for and design of a randomized controlled trial. BMC Gastroenterol. 2020;20(1):64.CrossRefPubMedPubMedCentral Forbes N, Elmunzer BJ, Allain T, Chau M, Koury HF, Bass S, Belletrutti PJ, Cole MJ, Gonzalez-Moreno E, Kayal A, et al. Infection control in ERCP using a duodenoscope with a disposable cap (ICECAP): rationale for and design of a randomized controlled trial. BMC Gastroenterol. 2020;20(1):64.CrossRefPubMedPubMedCentral
22.
go back to reference Trindade AJ, Copland A, Bhatt A, Bucobo JC, Chandrasekhara V, Krishnan K, Parsi MA, Kumta N, Law R, Pannala R, et al. Single-use duodenoscopes and duodenoscopes with disposable end caps. Gastrointest Endosc. 2021;93(5):997–1005.CrossRefPubMed Trindade AJ, Copland A, Bhatt A, Bucobo JC, Chandrasekhara V, Krishnan K, Parsi MA, Kumta N, Law R, Pannala R, et al. Single-use duodenoscopes and duodenoscopes with disposable end caps. Gastrointest Endosc. 2021;93(5):997–1005.CrossRefPubMed
23.
go back to reference Muthusamy VR, Bruno MJ, Kozarek RA, Petersen BT, Pleskow DK, Sejpal DV, Slivka A, Peetermans JA, Rousseau MJ, Tirrell GP, et al. Clinical evaluation of a single-use duodenoscope for endoscopic retrograde cholangiopancreatography. Clin Gastroenterol Hepatol. 2020;18(9):2108-2117.e2103.CrossRefPubMed Muthusamy VR, Bruno MJ, Kozarek RA, Petersen BT, Pleskow DK, Sejpal DV, Slivka A, Peetermans JA, Rousseau MJ, Tirrell GP, et al. Clinical evaluation of a single-use duodenoscope for endoscopic retrograde cholangiopancreatography. Clin Gastroenterol Hepatol. 2020;18(9):2108-2117.e2103.CrossRefPubMed
24.
go back to reference Napoléon B, Gonzalez JM, Grandval P, Lisotti A, Laquière AE, Boustière C, Barthet M, Prat F, Ponchon T, Donatelli G, et al. Evaluation of the performances of a single-use duodenoscope: Prospective multi-center national study. Dig Endosc. 2022;34(1):215–21.CrossRefPubMed Napoléon B, Gonzalez JM, Grandval P, Lisotti A, Laquière AE, Boustière C, Barthet M, Prat F, Ponchon T, Donatelli G, et al. Evaluation of the performances of a single-use duodenoscope: Prospective multi-center national study. Dig Endosc. 2022;34(1):215–21.CrossRefPubMed
25.
go back to reference Bang JY, Hawes R, Varadarajulu S. Equivalent performance of single-use and reusable duodenoscopes in a randomised trial. Gut. 2021;70(5):838–44.CrossRefPubMed Bang JY, Hawes R, Varadarajulu S. Equivalent performance of single-use and reusable duodenoscopes in a randomised trial. Gut. 2021;70(5):838–44.CrossRefPubMed
26.
go back to reference Slivka A, Ross AS, Sejpal DV, Petersen BT, Bruno MJ, Pleskow DK, Muthusamy VR, Chennat JS, Krishnamoorthi R, Lee C, et al. Single-use duodenoscope for ERCP performed by endoscopists with a range of experience in procedures of variable complexity. Gastrointest Endosc. 2021;94(6):1046–55.CrossRefPubMed Slivka A, Ross AS, Sejpal DV, Petersen BT, Bruno MJ, Pleskow DK, Muthusamy VR, Chennat JS, Krishnamoorthi R, Lee C, et al. Single-use duodenoscope for ERCP performed by endoscopists with a range of experience in procedures of variable complexity. Gastrointest Endosc. 2021;94(6):1046–55.CrossRefPubMed
27.
go back to reference Forbes N, Elmunzer BJ, Allain T, Parkins MD, Sheth PM, Waddell BJ, Du K, Douchant K, Oladipo O, Saleem A, et al. Effect of disposable elevator cap duodenoscopes on persistent microbial contamination and technical performance of endoscopic retrograde cholangiopancreatography: the ICECAP Randomized Clinical Trial. JAMA Intern Med. 2023;183(3):191–200. Forbes N, Elmunzer BJ, Allain T, Parkins MD, Sheth PM, Waddell BJ, Du K, Douchant K, Oladipo O, Saleem A, et al. Effect of disposable elevator cap duodenoscopes on persistent microbial contamination and technical performance of endoscopic retrograde cholangiopancreatography: the ICECAP Randomized Clinical Trial. JAMA Intern Med. 2023;183(3):191–200.
28.
go back to reference Loperfido S, Angelini G, Benedetti G, Chilovi F, Costan F, De Berardinis F, De Bernardin M, Ederle A, Fina P, Fratton A. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc. 1998;48(1):1–10.CrossRefPubMed Loperfido S, Angelini G, Benedetti G, Chilovi F, Costan F, De Berardinis F, De Bernardin M, Ederle A, Fina P, Fratton A. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc. 1998;48(1):1–10.CrossRefPubMed
29.
go back to reference Chen M, Wang L, Wang Y, Wei W, Yao YL, Ling TS, Shen YH, Zou XP. Risk factor analysis of post-ERCP cholangitis: a single-center experience. Hepatobil Pancreat Dis Int. 2018;17(1):55–8.CrossRef Chen M, Wang L, Wang Y, Wei W, Yao YL, Ling TS, Shen YH, Zou XP. Risk factor analysis of post-ERCP cholangitis: a single-center experience. Hepatobil Pancreat Dis Int. 2018;17(1):55–8.CrossRef
30.
go back to reference Lee JG, Lee CE. Infection after ERCP, and antibiotic prophylaxis: a sequential quality-improvement approach over 11 years. Gastrointest Endosc. 2008;67(3):476–7.CrossRefPubMed Lee JG, Lee CE. Infection after ERCP, and antibiotic prophylaxis: a sequential quality-improvement approach over 11 years. Gastrointest Endosc. 2008;67(3):476–7.CrossRefPubMed
31.
go back to reference Navaneethan U, Jegadeesan R, Nayak S, Lourdusamy V, Sanaka MR, Vargo JJ, Parsi MA. ERCP-related adverse events in patients with primary sclerosing cholangitis. Gastrointest Endosc. 2015;81(2):410–9.CrossRefPubMed Navaneethan U, Jegadeesan R, Nayak S, Lourdusamy V, Sanaka MR, Vargo JJ, Parsi MA. ERCP-related adverse events in patients with primary sclerosing cholangitis. Gastrointest Endosc. 2015;81(2):410–9.CrossRefPubMed
32.
go back to reference Motte S, Deviere J, Dumonceau JM, Serruys E, Thys JP, Cremer M. Risk factors for septicemia following endoscopic biliary stenting. Gastroenterology. 1991;101(5):1374–81.CrossRefPubMed Motte S, Deviere J, Dumonceau JM, Serruys E, Thys JP, Cremer M. Risk factors for septicemia following endoscopic biliary stenting. Gastroenterology. 1991;101(5):1374–81.CrossRefPubMed
33.
go back to reference Thiruvengadam NR, Kouanda A, Kalluri A, Schaubel D, Saumoy M, Forde K, Song J, Faggen A, Davis BG, Onwugaje KC, et al. A prospective cohort study evaluating PAN-PROMISE, a patient-reported Outcome Measure to Detect Post-ERCP Morbidity. Clin Gastroenterol Hepatol. 2022;S1542-3565(22):830-8. Thiruvengadam NR, Kouanda A, Kalluri A, Schaubel D, Saumoy M, Forde K, Song J, Faggen A, Davis BG, Onwugaje KC, et al. A prospective cohort study evaluating PAN-PROMISE, a patient-reported Outcome Measure to Detect Post-ERCP Morbidity. Clin Gastroenterol Hepatol. 2022;S1542-3565(22):830-8.
34.
go back to reference Larsen S, Russell RV, Ockert LK, Spanos S, Travis HS, Ehlers LH, Mærkedahl A. Rate and impact of duodenoscope contamination: a systematic review and meta-analysis. EClinicalMedicine. 2020;25: 100451.CrossRefPubMedPubMedCentral Larsen S, Russell RV, Ockert LK, Spanos S, Travis HS, Ehlers LH, Mærkedahl A. Rate and impact of duodenoscope contamination: a systematic review and meta-analysis. EClinicalMedicine. 2020;25: 100451.CrossRefPubMedPubMedCentral
35.
go back to reference Bomman S, Ashat M, Nagra N, Jayaraj M, Chandra S, Kozarek RA, Ross A, Krishnamoorthi R. Contamination rates in duodenoscopes reprocessed using enhanced surveillance and reprocessing techniques: a systematic review and meta-analysis. Clin Endosc. 2022;55(1):33–40.CrossRefPubMedPubMedCentral Bomman S, Ashat M, Nagra N, Jayaraj M, Chandra S, Kozarek RA, Ross A, Krishnamoorthi R. Contamination rates in duodenoscopes reprocessed using enhanced surveillance and reprocessing techniques: a systematic review and meta-analysis. Clin Endosc. 2022;55(1):33–40.CrossRefPubMedPubMedCentral
36.
go back to reference Gao L, Xu T, Huang G, Jiang S, Gu Y, Chen F. Oral microbiomes: more and more importance in oral cavity and whole body. Protein Cell. 2018;9(5):488–500.CrossRefPubMedPubMedCentral Gao L, Xu T, Huang G, Jiang S, Gu Y, Chen F. Oral microbiomes: more and more importance in oral cavity and whole body. Protein Cell. 2018;9(5):488–500.CrossRefPubMedPubMedCentral
37.
go back to reference Hu H, Shao W, Liu Q, Liu N, Wang Q, Xu J, Zhang X, Weng Z, Lu Q, Jiao L, et al. Gut microbiota promotes cholesterol gallstone formation by modulating bile acid composition and biliary cholesterol secretion. Nat Commun. 2022;13(1):252.CrossRefPubMedPubMedCentral Hu H, Shao W, Liu Q, Liu N, Wang Q, Xu J, Zhang X, Weng Z, Lu Q, Jiao L, et al. Gut microbiota promotes cholesterol gallstone formation by modulating bile acid composition and biliary cholesterol secretion. Nat Commun. 2022;13(1):252.CrossRefPubMedPubMedCentral
38.
go back to reference Grigor'eva IN, Romanova TI. Gallstone disease and microbiome. Microorganisms. 2020;8(6):835. Grigor'eva IN, Romanova TI. Gallstone disease and microbiome. Microorganisms. 2020;8(6):835.
39.
go back to reference Shen H, Ye F, Xie L, Yang J, Li Z, Xu P, Meng F, Li L, Chen Y, Bo X, et al. Metagenomic sequencing of bile from gallstone patients to identify different microbial community patterns and novel biliary bacteria. Sci Rep. 2015;5:17450.CrossRefPubMedPubMedCentral Shen H, Ye F, Xie L, Yang J, Li Z, Xu P, Meng F, Li L, Chen Y, Bo X, et al. Metagenomic sequencing of bile from gallstone patients to identify different microbial community patterns and novel biliary bacteria. Sci Rep. 2015;5:17450.CrossRefPubMedPubMedCentral
40.
go back to reference Walker MY, Pratap S, Southerland JH, Farmer-Dixon CM, Lakshmyya K, Gangula PR. Role of oral and gut microbiome in nitric oxide-mediated colon motility. Nitric Oxide. 2018;73:81–8.CrossRefPubMed Walker MY, Pratap S, Southerland JH, Farmer-Dixon CM, Lakshmyya K, Gangula PR. Role of oral and gut microbiome in nitric oxide-mediated colon motility. Nitric Oxide. 2018;73:81–8.CrossRefPubMed
41.
go back to reference Bhandari S, Reddy M, Shahzad G. Association between oral hygiene and ultrasound-confirmed gallstone disease in US population. Eur J Gastroenterol Hepatol. 2017;29(7):861–2.CrossRefPubMed Bhandari S, Reddy M, Shahzad G. Association between oral hygiene and ultrasound-confirmed gallstone disease in US population. Eur J Gastroenterol Hepatol. 2017;29(7):861–2.CrossRefPubMed
42.
go back to reference Ye F, Shen H, Li Z, Meng F, Li L, Yang J, Chen Y, Bo X, Zhang X, Ni M. Influence of the biliary system on biliary bacteria revealed by bacterial communities of the human biliary and upper digestive tracts. PLoS ONE. 2016;11(3): e0150519.CrossRefPubMedPubMedCentral Ye F, Shen H, Li Z, Meng F, Li L, Yang J, Chen Y, Bo X, Zhang X, Ni M. Influence of the biliary system on biliary bacteria revealed by bacterial communities of the human biliary and upper digestive tracts. PLoS ONE. 2016;11(3): e0150519.CrossRefPubMedPubMedCentral
43.
go back to reference Komiyama EY, Lepesqueur LS, Yassuda CG, Samaranayake LP, Parahitiyawa NB, Balducci I, Koga-Ito CY. Enterococcus species in the oral cavity: prevalence, virulence factors and antimicrobial susceptibility. PLoS ONE. 2016;11(9): e0163001.CrossRefPubMedPubMedCentral Komiyama EY, Lepesqueur LS, Yassuda CG, Samaranayake LP, Parahitiyawa NB, Balducci I, Koga-Ito CY. Enterococcus species in the oral cavity: prevalence, virulence factors and antimicrobial susceptibility. PLoS ONE. 2016;11(9): e0163001.CrossRefPubMedPubMedCentral
44.
go back to reference Kitamoto S, Nagao-Kitamoto H, Jiao Y, Gillilland MG, Hayashi A, Imai J, Sugihara K, Miyoshi M, Brazil JC, Kuffa P, et al. The intermucosal connection between the mouth and gut in commensal pathobiont-driven colitis. Cell. 2020;182(2):447-462.e414.CrossRefPubMedPubMedCentral Kitamoto S, Nagao-Kitamoto H, Jiao Y, Gillilland MG, Hayashi A, Imai J, Sugihara K, Miyoshi M, Brazil JC, Kuffa P, et al. The intermucosal connection between the mouth and gut in commensal pathobiont-driven colitis. Cell. 2020;182(2):447-462.e414.CrossRefPubMedPubMedCentral
Metadata
Title
Transmission of oral microbiota to the biliary tract during endoscopic retrograde cholangiography
Authors
Maria Effenberger
Ramona Al-Zoairy
Ronald Gstir
Ivo Graziadei
Hubert Schwaighofer
Herbert Tilg
Heinz Zoller
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2023
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-023-02721-7

Other articles of this Issue 1/2023

BMC Gastroenterology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.